Performance
Revenue ($m)
$2,553mOperating profit ($m)
$582mCore¹ operating profit ($m)
$632mEBITDA² ($m)
$727mProfit to shareholders ($m)
$421mBasic earnings per share³ (cents)
182cCore basic earnings per share³ (cents)
195cDividend per share (cents)
54c- Core results are presented to show the underlying performance of the Group, excluding the exceptional items and other adjustments set out in Note 6 of the Group consolidated financial statements
- EBITDA is earnings before interest, tax, depreciation, amortisation, asset write-down and impairment charges
- In June 2020, Hikma purchased 12.8 million ordinary shares from Boehringer Ingelheim,
which are being held in treasury
Four reasons to invest in Hikma
We have a strong business model with significant opportunities to further enhance our portfolio to drive growth and deliver value for shareholders.
Understanding Hikma
Find out how our business model, strategy and established capabilities support our clear investment proposition
Investors calendar
4 August 2022
2022 Interim Results Announcement
3 November 2022
November Trading Update
Results and presentations
Hikma 2021 Preliminary Results. Watch Siggi Olafsson, CEO and Khalid Nabilsi, CFO
Regulatory news
News feed from the London Stock Exchange's Regulatory News Service.
Download our Corporate Factsheet
Information on the high standards of governance we’re committed to, our governance structure, Board, key committees, and remuneration policy.